Abstract
Objectives: To determine if myasthenia gravis (MG) with antibodies to MuSK is a distinct subgroup of seronegative MG.
Methods: We assayed antibodies to muscle specific tyrosine kinase (MuSK) in 55 MG patients who had no antibodies to acetylcholine receptors and looked for the specific phenotype, comparing clinical features of anti-MuSK positive and anti-MuSK negative MG patients.
Results: MG with anti-MuSK antibodies was characterised by a striking prevalence of female patients (15 women, two men). Age at onset ranged from 22 to 52 years, with 70.6% of patients presenting at <40 years of age. The majority of patients (82.4%) had prevalent involvement of facial and bulbar muscles. One third of them did not respond well to anticholinesterase drugs. Steroid immunosuppression was effective in eight patients (44.4%). Nine patients underwent thymectomy; six of these had no thymus pathology, while three had a hyperplastic thymus. At the end of the observation period, six (35.3%) patients were in remission, five (29.4%) improved, four (23.6%) did not change, and two (11.7%) had died.
Conclusions: MG patients with antibodies to MuSK have characteristic clinical features that are different from features of the remaining seronegative MG patients. This emphasises the predictive value of anti-MuSK antibody analysis in seronegative MG patients.
Full Text
The Full Text of this article is available as a PDF (63.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Besinger U. A., Toyka K. V., Hömberg M., Heininger K., Hohlfeld R., Fateh-Moghadam A. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology. 1983 Oct;33(10):1316–1321. doi: 10.1212/wnl.33.10.1316. [DOI] [PubMed] [Google Scholar]
- Burges J., Vincent A., Molenaar P. C., Newsom-Davis J., Peers C., Wray D. Passive transfer of seronegative myasthenia gravis to mice. Muscle Nerve. 1994 Dec;17(12):1393–1400. doi: 10.1002/mus.880171208. [DOI] [PubMed] [Google Scholar]
- Evoli Amelia, Tonali Pietro A., Padua Luca, Monaco Mauro Lo, Scuderi Flavia, Batocchi Anna P., Marino Mariapaola, Bartoccioni Emanuela. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain. 2003 Jun 23;126(Pt 10):2304–2311. doi: 10.1093/brain/awg223. [DOI] [PubMed] [Google Scholar]
- Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001 Mar;7(3):365–368. doi: 10.1038/85520. [DOI] [PubMed] [Google Scholar]
- Lindstrom J. M. Acetylcholine receptors and myasthenia. Muscle Nerve. 2000 Apr;23(4):453–477. doi: 10.1002/(sici)1097-4598(200004)23:4<453::aid-mus3>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- McConville John, Farrugia Maria Elena, Beeson David, Kishore Uday, Metcalfe Richard, Newsom-Davis John, Vincent Angela. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol. 2004 Apr;55(4):580–584. doi: 10.1002/ana.20061. [DOI] [PubMed] [Google Scholar]
- Ohta K., Shigemoto K., Kubo S., Maruyama N., Abe Y., Ueda N., Ohta M. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG. Neurology. 2004 Jun 8;62(11):2132–2133. doi: 10.1212/01.wnl.0000129274.12702.92. [DOI] [PubMed] [Google Scholar]
- Sanders D. B., El-Salem K., Massey J. M., McConville J., Vincent A. Clinical aspects of MuSK antibody positive seronegative MG. Neurology. 2003 Jun 24;60(12):1978–1980. doi: 10.1212/01.wnl.0000065882.63904.53. [DOI] [PubMed] [Google Scholar]
- Scuderi Flavia, Marino Mariapaola, Colonna Lucrezia, Mannella Francesca, Evoli Amelia, Provenzano Carlo, Bartoccioni Emanuela. Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement. Lab Invest. 2002 Sep;82(9):1139–1146. doi: 10.1097/01.lab.0000028144.48023.9b. [DOI] [PubMed] [Google Scholar]
- Selcen Duygu, Fukuda Taku, Shen Xin-Ming, Engel Andrew G. Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology. 2004 Jun 8;62(11):1945–1950. doi: 10.1212/01.wnl.0000128048.23930.1d. [DOI] [PubMed] [Google Scholar]
- Vincent Angela, Bowen John, Newsom-Davis John, McConville John. Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol. 2003 Feb;2(2):99–106. doi: 10.1016/s1474-4422(03)00306-5. [DOI] [PubMed] [Google Scholar]
- Yeh Jiann-Horng, Chen Wei-Hung, Chiu Hou-Chang, Vincent Angela. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology. 2004 Jun 8;62(11):2131–2132. doi: 10.1212/01.wnl.0000128042.28877.c3. [DOI] [PubMed] [Google Scholar]
- Zhou Lan, McConville John, Chaudhry Vinay, Adams Robert N., Skolasky Richard L., Vincent Angela, Drachman Daniel B. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle Nerve. 2004 Jul;30(1):55–60. doi: 10.1002/mus.20069. [DOI] [PubMed] [Google Scholar]